Clinical Trials Logo

Clinical Trial Summary

The main hypothesis of this study is that peripheral magnetic neuromodulation can correct the symptoms of lower urinary tract in men. We assume that under the influence of t peripheral magnetic stimulation, both the subjective state of patients assessed by standardized questionnaires and a urination diary, as well as the objective parameters, assessed by non-invasive urodynamic studies, will be improved. This study will use standard protocols built into the BTL Emsella magnetic stimulator.


Clinical Trial Description

The aim of the study is to test the hypothesis that the use of the peripheral magnetic stimulation in men with lower urinary tract symptoms will help to reduce subjective and objective clinical symptoms and improve the quality of life of patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04807569
Study type Interventional
Source Joint-Stock Company North-West Center for Evidence-Based Medicine, Russian Federation
Contact Gleb Kovalev, MD
Phone +78126004712
Email kovalev2207@gmail.com
Status Not yet recruiting
Phase N/A
Start date April 1, 2021
Completion date April 1, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04721210 - The Effectiveness of Transcranial Magnetic Stimulation of Supplementary Motor Area (SMA) in Patients With Bladder Hypersensitivity and Bladder Pain N/A